Physician Perspectives on Real-World Evidence for Prescribing to Older Patients

Rand LZG, Wang J, Woloshin S, Wang SV, Darrow JJ, Kesselheim AS - Journal of Pharmacy Practice

  • Regulation and Clinical Evidence

Summary:

Interviewed physicians saw real-world evidence (RWE) as valuable for filling evidence gaps when prescribing medications to older adults, but expressed concerns about data quality, confounding, and interpretation of such information, emphasizing reliance on trusted sources such as professional guidelines. Closer collaboration between RWE researchers and guideline developers is necessary to ensure actionable, clinically meaningful dissemination of RWE.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

The Impact of Semantics in Medicines Regulation

Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence